Roche is partnering with Pfizer to offer people who test negative for COVID-19 free advice on how to get the best treatment options.
Roche's COVID-19 test has been updated to include a QR code that directs users to the CDC website where they can find more information on the virus and treatment options.
Pfizer markets the COVID vaccine Comirnaty and a new, bivalent vaccine, as well as the antivirals Paxlovid and Zyprexa. Roche and Pfizer want people to know about each other's COVID products, and their new tests will help people learn more about those products.
Roche's COVID-19 at-home test can detect the virus in as little as 20 minutes and is available for people up to age 60. Roche and Pfizer are partners in a new initiative initiated by the U.S. government to help increase access to testing. Roche's COVID-19 test detects virus particles in nasal passages and is widely used in the U.S., where it is cheaper and easier to get than other tests.
CDC says that 9 out of 10 people are struggling to comprehend and access personal and public health information because it contains confusing or confusing terms. Roche and Pfizer have created a tool that will help users with simple ways to find and use information about COVID. The product will provide a QR code that connects to the Pfizers COVID-19 site.
It was found that a test could detect the viral nucleocapsidase protein from SARS-CoV-2 in nasal fluid samples. In a clinical trial, the test showed that it was sensitive to 93.2% of cases and specific to 100% of cases. The test detected 99.8% of cases of COVID-19 in 158 samples from a population of about 65,000 people.
Roche has sold more than 1.8 billion COVID-19 tests worldwide since 2008, including lab-based molecule diagnostics and antibody tests.